LXRX (LXRX): Results for Last 10 Financial Years (Summary)

Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

0.805

Today's Change

-0.015 (1.82%)

Day's Change

0.791 - 0.85

Trading Volume

2,017,551

Financial

Market Cap

290 Million

Shares Outstanding

361 Million

Latest Quarter

30-Sep-2024 [Q3]

Announcement Date

13-Nov-2024

Reported Currency

USD

Revenue QoQ | YoY

6.25% | 980.25%

NP QoQ | YoY

-21.30% | -28.28%

Latest Audited

31-Dec-2023

Announcement Date

25-Mar-2024

Reported Currency

USD

Revenue | Net Profit

1,204,000.00 | -177,119,000.00

EPS | EPS Diluted

-0.80 Cent | -0.80 Cent

YoY

-71.75%

NP Margin

-14,710.88%

Reported Currency in USD

Show?

YoY %

Horiz. %

	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Last 10 FY Result (Thousand)
Revenue	1,204	139	298	23,995	322,073	63,209	90,335	83,337	130,014	22,854	-27.88%
YoY %	766.19%	-53.36%	-98.76%	-92.55%	409.54%	-30.03%	8.40%	-35.90%	468.89%	-	-
Horiz. %	5.27%	0.61%	1.30%	104.99%	1,409.26%	276.58%	395.27%	364.65%	568.89%	100.00%	-
PBT	-177,119	-101,944	-87,758	-58,574	124,119	-120,548	-141,711	-141,429	-4,682	-100,364	6.51%
YoY %	-73.74%	-16.16%	-49.82%	-147.19%	202.96%	14.93%	-0.20%	-2,920.70%	95.33%	-	-
Horiz. %	176.48%	101.57%	87.44%	58.36%	-123.67%	120.11%	141.20%	140.92%	4.67%	100.00%	-
Tax	0	1,184	510	11,610	-6,014	3,508	-12,661	4,511	5,995	-70	-
YoY %	0.00%	132.16%	-95.61%	293.05%	-271.44%	127.71%	-380.67%	-24.75%	8,664.29%	-	-
Horiz. %	0.00%	-1,691.43%	-728.57%	-16,585.71%	8,591.43%	-5,011.43%	18,087.14%	-6,444.29%	-8,564.29%	100.00%	-
NP	-177,119	-103,128	-88,268	-70,184	130,133	-120,548	-129,050	-141,429	-4,682	-100,294	6.51%
YoY %	-71.75%	-16.84%	-25.77%	-153.93%	207.95%	6.59%	8.75%	-2,920.70%	95.33%	-	-
Horiz. %	176.60%	102.83%	88.01%	69.98%	-129.75%	120.19%	128.67%	141.01%	4.67%	100.00%	-
Tax Rate	-	-	-	-	4.85%	-	-	-	-	-	-
YoY %	-	-	-	-	0.00%	-	-	-	-	-	-
Horiz. %	-	-	-	-	100.00%	-	-	-	-	-	-
Total Cost	178,323	103,267	88,566	94,179	191,940	183,757	219,385	224,766	134,696	123,148	4.19%
YoY %	72.68%	16.60%	-5.96%	-50.93%	4.45%	-16.24%	-2.39%	66.87%	9.38%	-	-
Horiz. %	144.80%	83.86%	71.92%	76.48%	155.86%	149.22%	178.15%	182.52%	109.38%	100.00%	-

	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Ratio Analysis
NP Margin	-14,710.88	-74,192.81	-29,620.13	-292.49	40.40	-190.71	-142.86	-169.71	-3.60	-438.85	47.69%
YoY %	80.17%	-150.48%	-10,026.89%	-823.99%	121.18%	-33.49%	15.82%	-4,614.17%	99.18%	-	-
Horiz. %	3,352.14%	16,906.19%	6,749.49%	66.65%	-9.21%	43.46%	32.55%	38.67%	0.82%	100.00%	-

	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Per Share
EPS	-0.80	-0.62	-0.61	-0.63	1.23	-1.14	-1.23	-1.36	-0.05	-1.31	-5.32%
YoY %	-29.03%	-1.64%	3.17%	-151.22%	207.89%	7.32%	9.56%	-2,620.00%	96.18%	-	-
Horiz. %	61.07%	47.33%	46.56%	48.09%	-93.89%	87.02%	93.89%	103.82%	3.82%	100.00%	-
EPS Diluted	-0.80	-0.62	-0.61	-0.63	1.11	-1.14	-1.23	-1.36	-0.05	-1.31	-5.32%
YoY %	-29.03%	-1.64%	3.17%	-156.76%	197.37%	7.32%	9.56%	-2,620.00%	96.18%	-	-
Horiz. %	61.07%	47.33%	46.56%	48.09%	-84.73%	87.02%	93.89%	103.82%	3.82%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 0 of 0 comments

Latest Videos